MICHAEL MASON: Open Payments
NPI 1487926549 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,302 in 45 payments from 8 companies in 2025. Trend: 2023 $351 · 2024 $517 · 2025 $1,302
Food & beverage: $1,302
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $468 |
| Madrigal Pharmaceuticals | 4 | $301 |
| GENZYME CORPORATION | 3 | $157 |
| Novo Nordisk Inc | 2 | $127 |
| Janssen Biotech, Inc. | 4 | $99 |
| PFIZER INC. | 4 | $73 |
| Aimmune Therapeutics, Inc. | 2 | $67 |
| Phathom Pharmaceuticals, Inc. | 1 | $10 |
Products named: REZDIFFRA, MAVYRET, LINZESS, DUPIXENT, Wegovy, TREMFYA, VOWST, CREON.
Industry payments across MD — which companies pay providers there.
